If you’ve started looking into prescription weight loss medications, you’ve probably run into two names that sound almost the same. Liraglutide and semaglutide. They belong to the same family, they both come as injections, and both get talked about in the same breath. So what’s actually different?
At Lumea Med Spa, we hear this question a lot. People want to know which one is “better,” and the real answer is that it depends on you. In this blog post, we’ll walk through how the two compare on dosing, results, side effects and safety, so you can have a clearer conversation with a provider.
A quick note before we start. These are prescription medications. They aren’t right for everyone, and no medication can guarantee weight loss. Results vary from person to person, and everything here is general education, not a recommendation for your situation.
What liraglutide and semaglutide have in common
Both drugs are GLP-1 receptor agonists. That’s a long name for a simple idea. They copy a natural gut hormone called GLP-1, which your body releases after you eat. The FDA labeling for both medications notes that they slow how fast your stomach empties, which is one reason people tend to feel full sooner and for longer.
Both are approved as an add-on to a reduced-calorie diet and more physical activity. They’re tools, not shortcuts. That matches how we think about them in our medical weight loss program, where medication is one part of a bigger plan that also includes nutrition, movement and follow-up.

Both are given by injection under the skin, usually in the belly, thigh or upper arm. And both carry the same kind of boxed warning, which we’ll cover in the safety section below.
How liraglutide works for weight loss
Liraglutide is the older of the two. For weight management, it’s sold under the brand name Saxenda. You may also hear the name Victoza, which is a liraglutide product used for type 2 diabetes. Saxenda is the version made for chronic weight management.
According to the Saxenda prescribing information, it’s approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes or abnormal cholesterol. It’s also approved for certain adolescents aged 12 and older.
The key practical detail is the schedule. Liraglutide is injected once a day. You start with a low dose for a week, then step up each week until you reach the recommended dose of 3 mg daily. People who like routine often don’t mind a daily habit. Others find it a lot to keep up with.
How semaglutide works for weight loss
Semaglutide is the newer option, and for weight management it’s sold under the brand name Wegovy. It also appears under the name Ozempic, which is the version labeled for type 2 diabetes.
The Wegovy prescribing information lists two main uses. One is to reduce excess body weight and help maintain weight reduction in adults with obesity or with overweight plus a related condition. The other is to lower the risk of major cardiovascular events, like heart attack or stroke, in adults who already have cardiovascular disease and either obesity or overweight. A pill form of Wegovy now exists as well, though most clients ask us about the injection.
The injection is given once a week, not once a day. The label describes starting with a small dose for four weeks and stepping up every four weeks, with a usual maintenance dose of 2.4 mg weekly. That’s a very different rhythm from liraglutide.
Dosing and schedule: the biggest day-to-day difference
If you’re comparing these two in real life, this is where you’ll feel the gap first.
Liraglutide means one injection a day, every day. Semaglutide means one injection a week, on the same day. Both start low and increase slowly to give your body time to adjust. That gradual step-up is built into both labels because side effects tend to be milder when the dose rises slowly.
The step-up is slower for semaglutide. In the head-to-head trial we’ll describe next, the semaglutide group took 16 weeks to reach full dose, while the liraglutide group took 4 weeks. So a weekly shot doesn’t mean a faster start. It means fewer injections once you’re on a steady dose.
For many people, convenience plays a bigger role than they expect. A medication you can stick with is worth more than one that looks good on paper but feels like a chore. If you’re curious how this compares to another popular option, our guide to semaglutide versus tirzepatide covers that pair.
What does the research say about results?
This is the question most people really want answered. Do these two work the same?
Until recently, many comparisons were made by lining up separate studies. That’s tricky, because different trials use different people and different rules. A better comparison comes from a direct, side-by-side trial called STEP 8, published in JAMA. In that randomized clinical trial, 338 adults with overweight or obesity and without diabetes took either weekly semaglutide or daily liraglutide, along with diet and activity counseling, for 68 weeks.
The authors reported that semaglutide led to significantly greater weight loss on average than liraglutide over that time. Both drugs did better than placebo. In plain terms, when the two were compared directly under the same conditions, semaglutide produced a bigger average change on the scale.
We want to be careful here, because averages don’t tell you what will happen to you. Some people lose more on liraglutide than the average semaglutide user, and some lose less on either one. We won’t quote percentages, because individual results vary a lot and no outcome is guaranteed. The most useful takeaway is that the two medications aren’t interchangeable, and the research gives an edge on average to semaglutide in that trial.
A few more things worth knowing about that study. It was open-label, meaning participants and researchers knew which active drug was being used. It lasted 68 weeks, or about 16 months. And it studied people without diabetes, so it may not apply the same way to everyone.
What about liraglutide weight loss on its own?
Liraglutide is still a real, FDA-approved option for weight management, and it has helped many people. Being the older medication, it has a long record of use. For some clients, a daily injection, tolerability or other health factors make it a sensible conversation. “Less effective on average” doesn’t mean “wrong for you.”
Side effects: more alike than different
Both medications share the same pattern of side effects, and most of them involve the stomach. The FDA labels list nausea, diarrhea, constipation, vomiting and abdominal pain among the most common. Headache, fatigue, dizziness and indigestion also show up on both lists. Injection site reactions are noted for liraglutide, and hair loss appears on the semaglutide list.
In that trial, a similar share of people in each group reported stomach-related side effects. More people stopped liraglutide for any reason during the trial than stopped semaglutide, though the reasons vary and we can’t say why in any one case.
Most side effects tend to be most noticeable when you start and when your dose goes up. That’s another reason for slow dose increases and regular check-ins. If something doesn’t feel right, don’t push through quietly. Tell your provider.
Safety: who should think twice
These are real medications with real warnings, so this section matters.
Both labels carry a boxed warning about the risk of thyroid C-cell tumors. In rodent studies, these drugs caused thyroid tumors. It isn’t known whether they do in people. Because of that, these medications aren’t for anyone with a personal or family history of medullary thyroid carcinoma or a condition called multiple endocrine neoplasia syndrome type 2. Tell your provider right away if you notice a lump or swelling in your neck, hoarseness or trouble swallowing.
Both labels also list other precautions. These include acute pancreatitis, gallbladder disease, low blood sugar when used with certain diabetes medicines, and increased heart rate. The liraglutide label also recommends monitoring for depression or suicidal thoughts. Allergic reactions are possible with either.
Pregnancy is another important point. The liraglutide label says it should not be used during pregnancy. The semaglutide label says to stop when pregnancy is recognized and to stop at least two months before a planned pregnancy because the drug stays in your system for a long time. If you’re pregnant, planning to be, or breastfeeding, talk to your provider before starting anything.
This is why a proper medical review comes first. Your history, your medications and your goals all shape whether either drug is appropriate at all.
How do you choose between them?
There’s no single right answer, and we don’t think anyone should decide from an article. But here are the questions we walk through with clients.
What fits your life? Daily versus weekly injections is a bigger deal than it sounds. Do you have other health conditions? Semaglutide has a labeled use for heart risk reduction in people with established cardiovascular disease, and that may matter to you. Have you used either before? Past experience, good or bad, gives your provider useful information. What are your safety considerations? Your health history may point toward one option, or toward neither. And what are your goals and budget? Coverage and cost vary a lot, so ask early.
In general, the comparison trial points to greater average weight loss with semaglutide. But “on average” isn’t “for everyone,” and the best medication is the one that’s safe for you and that you can keep taking as directed.
Cost, coverage and where your medication comes from
Costs vary depending on the medication, your insurance and your pharmacy. Some plans cover these drugs for certain diagnoses, and many don’t cover them for weight loss at all. It’s worth asking about coverage before you commit.
You may also hear about lower-priced versions from other sources. Whatever you’re offered, ask where it comes from and who is overseeing your treatment. These are prescription drugs, and the labels exist for a reason. A provider who monitors you, adjusts your dose and watches for side effects is part of what makes this a medical treatment.
What medication can’t do on its own
Both medications are labeled for use alongside diet and activity. That’s not just fine print. What you eat and how you move still shape your energy, your strength and how well results hold up.

Protein, fiber and whole foods help you feel good while your appetite is lower. Strength training helps protect muscle. And because these medications work while you’re taking them, planning for the long term matters. Our guide to medical weight loss versus going it alone explains why support makes a difference, and our post on Lipolean MIC B12 injections covers an add-on some clients ask about.
If you want more detail on one of the two drugs, our post on semaglutide for weight loss in Miami goes deeper on that medication.
What a weight loss consultation looks like at Lumea
At Lumea, we provide prescriptions for weight loss medications such as semaglutide, tirzepatide and liraglutide after a consultation with our in-house board certified doctor. We don’t decide before you walk in.
We start with your health history, current medications and any past attempts at weight loss. We often review lab work and screen for conditions like insulin resistance, thyroid issues or sleep apnea. Then we talk about your goals and which options, if any, make sense. If medication is appropriate, we explain the benefits and risks, set up a gradual plan and follow up to see how you’re doing.
Sometimes the right answer is liraglutide, sometimes it’s semaglutide, sometimes it’s a different medication, and sometimes it’s no medication at all. We’ll tell you plainly which one we think fits.
Frequently asked questions
Is semaglutide better than liraglutide for weight loss?
In a direct 68-week trial, semaglutide produced greater average weight loss than liraglutide. Individual results vary, and the right choice also depends on safety, convenience and your health history.
How often do you take each one?
Liraglutide is injected once a day. Semaglutide injection is given once a week.
What is liraglutide used for?
Liraglutide is sold for weight management under the brand name Saxenda and for type 2 diabetes under the name Victoza. The two products are labeled for different uses.
Do liraglutide and semaglutide have the same side effects?
They share many, especially nausea, diarrhea, constipation and vomiting. There are small differences in the lists, and each person responds differently.
Can I take liraglutide and semaglutide together?
No. They’re in the same drug class, and taking both isn’t something a provider would normally recommend. Never combine them without medical direction.
Are these medications safe for everyone?
No. Both carry a boxed warning about thyroid tumors and have other precautions. They aren’t recommended during pregnancy, and some health histories rule them out.
Will I regain weight if I stop?
It’s common for weight to come back after stopping any weight loss medication, especially if habits haven’t changed. That’s why we focus on a long-term plan, not just a prescription.
How long does it take to see results?
Both start at low doses and increase gradually, so changes tend to build slowly. We can’t predict your timeline, but your provider will check in regularly to see how you’re responding.
Ready to talk it through?
If you’re weighing these two medications, the best next step is a conversation with a provider who can look at your full picture. We’ll listen to your goals, review your health history and explain your options in plain language.
You’ll find us at Town Center One in Miami, near Dadeland and Kendall. Contact Lumea Med Spa to schedule a consultation and start with a plan that fits you.
This article is general education and not medical advice. Prescription medications should be started, adjusted and stopped only under the direction of a licensed provider who knows your health history. Results vary, and no outcome is guaranteed.
Sources
Novo Nordisk. Saxenda (liraglutide) injection prescribing information, via DailyMed (U.S. National Library of Medicine). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7b11f6ac-4c27-4748-9e65-22d4cf3adfb4
Novo Nordisk. Wegovy (semaglutide) prescribing information, via DailyMed (U.S. National Library of Medicine). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
Rubino DM, et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA, 2022. https://pubmed.ncbi.nlm.nih.gov/35015037/


